Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-NDDP (Aroplatin) in Malignant Pleural Mesothelioma
NCT00004033Phase 2Completed
- Sponsor
- NYU Langone Health
- Start
- Sep 1998
- Primary completion
- May 2001
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liposomal NDDP in malignant pleural mesothelioma (MPM), sponsored by NYU Langone Health. Started Sep 1998; status: completed.
02
Drugs
liposomal NDDP
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT00004033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004033.